Caricamento...
Association between filgrastim biosimilar availability and changes in claim payments and Patient out-of-pocket costs for biologic Filgrastim Products
OBJECTIVE. To estimate the effect of filgrastim-sndz market entry on patient out-of-pocket costs and claim payments for filgrastim products. METHODS: This study used a single interrupted time series design with longitudinal, nationally representative, individual-level claims data from IBM MarketScan...
Salvato in:
| Pubblicato in: | Value Health |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7748066/ https://ncbi.nlm.nih.gov/pubmed/33248515 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jval.2020.06.014 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|